Literature DB >> 483371

Prednisolone in the treatment of pneumococcal meningitis.

O Bademosi, B O Osuntokun.   

Abstract

The results of a steroid on 52 Nigerians (27 males, 25 females, aged 10 to 59 years) with bacteriologically proven pneumococcal meningitis are presented. Twenty-four of the patients were treated with steroids in addition to a standard regime. The clinical features on admission in the two groups were comparable and management other than steroid administration identical. Personality change with impairment of intellect was more frequent and mortality higher in the steroid-treated group although the differences wre not statistically significant. It is concluded that steroids apparently have no beneficial effect and may worsen the prognosis in pneumococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 483371

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  4 in total

1.  Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data.

Authors:  Diederik van de Beek; Jeremy J Farrar; Jan de Gans; Nguyen Thi Hoang Mai; Elizabeth M Molyneux; Heikki Peltola; Tim E Peto; Irmeli Roine; Mathew Scarborough; Constance Schultsz; Guy E Thwaites; Phung Quoc Tuan; A H Zwinderman
Journal:  Lancet Neurol       Date:  2010-02-03       Impact factor: 44.182

Review 2.  Corticosteroids for acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Peter McIntyre; Kameshwar Prasad; Diederik van de Beek
Journal:  Cochrane Database Syst Rev       Date:  2015-09-12

3.  Dexamethasone and bacterial meningitis. A meta-analysis of randomized controlled trials.

Authors:  B J Geiman; A L Smith
Journal:  West J Med       Date:  1992-07

4.  Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.

Authors:  Aaron M Cook; G Morgan Jones; Gregory W J Hawryluk; Patrick Mailloux; Diane McLaughlin; Alexander Papangelou; Sophie Samuel; Sheri Tokumaru; Chitra Venkatasubramanian; Christopher Zacko; Lara L Zimmermann; Karen Hirsch; Lori Shutter
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.